Manufacturing Companies for Doxorubicin - Imatinib Mesylate (alpha form) CAS 220127-57-1 Ph+CML API High Quality – Ruifu

Short Description:


Product Detail

Related Products

Product Tags

Related Video

Feedback (2)

We have been experienced manufacturer. Wining the majority of the crucial certifications of its market for Weight 277.17, CAS 438056-69-0, CAS 42558-54-3, We are going to empower people by communicating and listening, Setting an example to others and learning from experience.
Manufacturing Companies for Doxorubicin - Imatinib Mesylate (alpha form) CAS 220127-57-1 Ph+CML API High Quality – Ruifu Detail:

Manufacturer with High Purity and Stable Quality
Commercial Supply Imatinib Mesylate (CAS: 220127-57-1) and Related Intermediates:
Imatinib Mesylate (alpha form) CAS: 220127-57-1
N-(2-Methyl-5-nitrophenyl)-4-(pyridin-3-yl)pyrimidin-2-amine CAS: 152460-09-8
N-(5-Amino-2-methylphenyl)-4-(3-pyridyl)-2-pyrimidinea CAS: 152460-10-1
4-[(4-Methylpiperazin-1-yl)methyl]benzoic acid dihydrochloride CAS: 106261-49-8

Chemical Name Imatinib Mesylate (alpha form)
Synonyms STI571 Mesylate; CGP-57148B; Imatinib Methanesulfonate
CAS Number 220127-57-1
CAT Number RF-API19
Stock Status In Stock, Production Scale Up to Tons
Molecular Formula C30H35N7O4S
Molecular Weight 589.71
Brand Ruifu Chemical
Item Specifications
Appearance White to Off-White Crystalline Powder
Solubility Easy to dissolve in the water
HPLC Identification Sample spectrum main peak retention time conforms with that 
IR Identification Infrared absorption spectrum of sample conforms with reference sample
Melting Point 214.0~222.0℃
Loss on Drying ≤0.50%
Residue on Ignition ≤0.10%
Heavy Metals ≤20ppm
Related Substances (1) Impurity G: NMT 0.3%
(2) Impurity B: NMT 0.3%
(3) Impurity C: NMT 0.3%
(4) Impurity D: NMT 0.3%
(5) Impurity A: NMT 0.3%
(6) Impurity H: NMT 0.3%
(7) Impurity F: NMT 0.3% 
(8) Impurity E: NMT 0.3%
(9) The biggest single impurity: NMT0.1%
Residual Solvents (1) Ethyl Acetate: NMT 5000ppm
(2) Methanol: NMT3000ppm
(3) Dichloromethane: NMT 600ppm
(4) Ethanol: NMT 5000ppm
(5) Toluene: NMT 890ppm
(6) Dimethyl Sulfoxide: NMT5000ppm
HPLC Assay 98.0%~102.0% (C30H35N7SO4 Calculated on the Anhydrous Basis)
Test Standard Enterprise Standard
Usage Active Pharmaceutical Ingredient (API); Ph+CML

Package: Bottle, Aluminum foil bag, Cardboard drum, 25kg/Drum, or according to customer’s requirement.

Storage Condition: Store in sealed containers at cool and dry place; Protect from light, moisture and pest infestation.

1
2

Imatinib mesylate is a small molecule that inhibits the c-Abl protein-tyrosine kinase, a kinase specifically important for proliferation of chronic myelogenous leukemia (CML). A translocation event between chromosomes 9 and 22 generates the Philadelphia chromosome, which then produces the Bcr-Abl fusion protein with aberrant kinase activity that promotes rapid cell proliferation. Imatinib mesylate binds up this crucial kinase, halting CML related growth. Imatinib mesylate has further been displayed to inhibit PDGFR and tyrosine kinases associated with c-Kit. Formulations containing Imatinib mesylate have been used in the treatment of various cancers.

Imatinib mesylate is A tyrosine kinase inhibitor. Highly specific for BCR-ABL, the enzyme associated with chronic myelogenous leukemia (CML) and certain forms of acute lymphoblastic leukemia (ALL).  It’s a potent and selective v-Abl tyrosine kinase inhibitor (IC50 = 38 nM). Also inhibits PDGFR and c-kit. Exhibits selectivity for v-Abl over a panel of other tyrosine and serine/threonine protein kinases. Selectively inhibits PDGF-stimulated growth of v-abl-transformed PB-3 cells and v-sis-transformed BALB/c 3T3 cells in vitro. Exhibits antitumor effects in mice bearing AMuLV or BABL/c 3T3 v-sis cells. Inhibits replication of SARS-CoV and MERS-CoV in vitro (EC50 values are 9.823 and 17.689 μM, respectively).


Product detail pictures:

Manufacturing Companies for Doxorubicin - Imatinib Mesylate (alpha form) CAS 220127-57-1 Ph+CML API High Quality – Ruifu detail pictures


Related Product Guide:

To meet the customers' over-expected satisfaction , we have our strong team to provide our best overall service which includes marketing, sales, designing, production, quality controlling, packing, warehousing and logistics for Manufacturing Companies for Doxorubicin - Imatinib Mesylate (alpha form) CAS 220127-57-1 Ph+CML API High Quality – Ruifu , The product will supply to all over the world, such as: Tunisia, Estonia, Bahamas, Ought to any of these products be of curiosity to you, remember to allow us to know. We are going to be satisfied to give you a quotation on receipt of one's in depth specs. We've our private experienced R&D enginners to meet any of one's requriements, We appear forward to receiving your enquires soon'and hope to have the opportunity to work together with you in the future. Welcome to check out our company.
  • This company has a lot of ready-made options to choose and also could custom new program according to our demand, which is very nice to meet our needs.
    5 Stars By Vanessa from Argentina - 2018.03.03 13:09
    Adhering to the business principle of mutual benefits, we have a happy and successful transaction, we think we will be the best business partner.
    5 Stars By Belle from Congo - 2017.09.28 18:29
    Write your message here and send it to us